Sunday, January 3, 2021

Approval for Covaxin a giant leap for novel product development in India: Bharat...

The phase-III human clinical trials of Covaxin began mid-November. Bharat Biotech aims to recruit 26,000 volunteers across the country for the phase-III trials.

Posted from: this blog via Microsoft Flow.

Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)